The real face of eczema in Europe

A new study found that the chronic and relapsing nature of atopic eczema can impact greatly on patient well-being and quality of life. [Anut21ng Photo/Shutterstock]

Atopic eczema has a long time been perceived as a superficial, trivial skin disease. However, a new study found that the chronic and relapsing nature of atopic eczema can impact greatly on patient well-being and quality of life.

Atopic eczema is one of the most common non-communicable inflammatory skin diseases, affecting 1-3% of adults in the EU who suffer from chronic or relapsing itching. For almost 10% of patients with atopic eczema, the condition is severe.

Subscribe to our newsletters

Subscribe
Contribute